Expertise in
4
conditions

Jurgen J. Futterer

Erasmus MC
Rotterdam, ZH, NL 
Expertise in
4
conditions
Erasmus MC
Rotterdam, ZH, NL 

Overview

Jurgen Futterer practices practicing medicine in Rotterdam, Netherlands.

Mr. Futterer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Facioscapulohumeral Muscular Dystrophy (FSHD), Renal Oncocytoma, Prostatectomy, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 220 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Erasmus MC
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
INCITE LS: A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
INCITE LS: A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
Enrollment Status: Terminated
Publish Date: August 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

220 Total Publications

(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.
(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.
Journal: BMJ open
Published: July 08, 2026

Frequently Asked Questions about Jurgen J. Futterer

Is Jurgen J. Futterer a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jurgen J. Futterer is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jurgen J. Futterer participate in research or clinical trials?

Yes. Jurgen J. Futterer has published 220 articles and abstracts on conditions like Prostate Cancer. You can view a list of Jurgen J. Futterer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Futterer's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile